Search

everythinglearnresearchcommunity

for

Search:↓

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Some birth control pills have a higher risk of blood clots than others.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Oral contraceptives often cause melasma and other skin issues.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormonal therapies are safe and effective for treating adult women's acne.

Certain hormone treatments can improve acne and related conditions in women.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.